These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4027315)

  • 1. What does the dexamethasone suppression test identify?
    Krishnan KR; France RD; Pelton S; McCann UD; Manepalli AN; Davidson JR
    Biol Psychiatry; 1985 Sep; 20(9):957-64. PubMed ID: 4027315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsuppression of cortisol in depression and immune function.
    Syvälahti E; Eskola J; Ruuskanen O; Laine T
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):413-22. PubMed ID: 4070644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age effects in serial hypothalamic-pituitary-adrenal monitoring.
    Greden JF; Flegel P; Haskett R; Dilsaver S; Carroll BJ; Grunhaus L; Genero N
    Psychoneuroendocrinology; 1986; 11(2):195-204. PubMed ID: 3749402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamic-pituitary-adrenal-axis hyperactivity in bulimia.
    Hudson JI; Pope HG; Jonas JM; Laffer PS; Hudson MS; Melby JC
    Psychiatry Res; 1983 Feb; 8(2):111-7. PubMed ID: 6574529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of outcome in depressed patients by weekly monitoring with the dexamethasone suppression test.
    Schweitzer I; Maguire KP; Gee AH; Tiller JW; Biddle N; Davies B
    Br J Psychiatry; 1987 Dec; 151():780-4. PubMed ID: 3502804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Learned helplessness: an experimental model of the DST in rats.
    Haracz JL; Minor TR; Wilkins JN; Zimmermann EG
    Biol Psychiatry; 1988 Feb; 23(4):388-96. PubMed ID: 3342268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of abnormal dexamethasone suppression test in alcoholics abstinent for four weeks.
    Del Porto JA; Monteiro MG; Laranjeira RR; Jorge MR; Masur J
    Biol Psychiatry; 1985 Nov; 20(11):1156-60. PubMed ID: 4052517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortisol and corticosterone response after syn-corticotropin in relationship to dexamethasone suppressibility of cortisol.
    Gerken A; Holsboer F
    Psychoneuroendocrinology; 1986; 11(2):185-94. PubMed ID: 3018821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the dexamethasone suppression test with DSM-III criteria in psychiatrically hospitalized adolescents.
    Evans DL; Nemeroff CB; Haggerty JJ; Pedersen CA
    Psychoneuroendocrinology; 1987; 12(3):203-9. PubMed ID: 3615749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine aspects of primary endogenous depression. II. Serum dexamethasone concentrations and hypothalamic-pituitary-adrenal cortical activity as determinants of the dexamethasone suppression test response.
    Poland RE; Rubin RT; Lesser IM; Lane LA; Hart PJ
    Arch Gen Psychiatry; 1987 Sep; 44(9):790-5. PubMed ID: 3632252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone suppression test in severe schizophrenic illness: effects of plasma dexamethasone and caffeine levels.
    Holsboer-Trachsler E; Buol C; Wiedemann K; Holsboer F
    Acta Psychiatr Scand; 1987 Jun; 75(6):608-13. PubMed ID: 3618283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPA axis dysregulation in men with hypersexual disorder.
    Chatzittofis A; Arver S; Öberg K; Hallberg J; Nordström P; Jokinen J
    Psychoneuroendocrinology; 2016 Jan; 63():247-53. PubMed ID: 26519779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight change and the dexamethasone suppression test.
    Krishnan KR; France RD; Snipes MT; Pelton S
    Biol Psychiatry; 1985 Sep; 20(9):1018-22. PubMed ID: 4027311
    [No Abstract]   [Full Text] [Related]  

  • 14. [Preliminary study of the dexamethasone suppression test in endogenous depression].
    Omori T; Denda K; Koyama T; Matsubara S; Yasuda M
    Seishin Shinkeigaku Zasshi; 1983; 85(11):816-9. PubMed ID: 6677917
    [No Abstract]   [Full Text] [Related]  

  • 15. The dexamethasone suppression test in agoraphobia.
    Peterson GA; Ballenger JC; Cox DP; Hucek A; Lydiard RB; Laraia MT; Trockman C
    J Clin Psychopharmacol; 1985 Apr; 5(2):100-2. PubMed ID: 3988966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dexamethasone suppression test repeated after a suicide attempt].
    Wilmotte J; Van Wettere JP; Depauw Y; Charles G
    Acta Psychiatr Belg; 1986; 86(3):242-8. PubMed ID: 3751647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weekly monitoring of dexamethasone suppression response in depression: its relationship to change of body weight and psychopathology.
    Gerken A; Maier W; Holsboer F
    Psychoneuroendocrinology; 1985; 10(3):261-71. PubMed ID: 4059474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dexamethasone suppression test (DST): clinical use in psychiatry].
    Morrissette L; Boucher H
    Union Med Can; 1986 Jan; 115(1):58-63. PubMed ID: 3952894
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of weight loss on the dexamethasone suppression test.
    Yerevanian BI; Baciewicz GJ; Iker HP; Privitera MR
    Psychiatry Res; 1984 Jun; 12(2):155-60. PubMed ID: 6591220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary-adrenal axis rhythm disturbances in psychiatric depression.
    Pfohl B; Sherman B; Schlechte J; Stone R
    Arch Gen Psychiatry; 1985 Sep; 42(9):897-903. PubMed ID: 2994590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.